Form 4: FMR LLC Reports Metsera Share Distributions and Minor Sale

FMR LLC, a significant shareholder in Metsera, Inc., disclosed a series of internal share distributions and a small sale of common stock.

Summary

• FMR LLC, identified as a 10% owner of Metsera, Inc. (MTSR), reported multiple transactions involving Metsera common stock.
• The transactions, primarily distributions without payment of consideration (Code J), occurred on September 2, 2025.
• F-Prime Capital Partners Life Sciences Fund VIII LP disposed of 1,350,000 shares and now beneficially owns 3,189,540 shares indirectly.
• F-Prime Capital Partners Life Sciences Advisors Fund VIII LP acquired and then disposed of 20,250 shares each, resulting in 0 shares beneficially owned indirectly.
• F-Prime Inc. acquired 895 shares and now beneficially owns 895 shares indirectly.
• Impresa Fund IV LLC acquired 997,312 shares, disposed of 997,044 shares via distribution, and subsequently sold 268 shares at $36 per share, resulting in 0 shares beneficially owned indirectly.
• An additional 1,134,258 shares were acquired by entities whose shares are subject to reporting by FMR LLC, now beneficially owning 1,134,258 shares indirectly.
• The transactions reflect internal re-allocations and a minor sale by entities affiliated with FMR LLC.

Sentiment

Score: 5

Explanation: The filing is largely neutral, reporting factual insider transactions, primarily internal distributions, with a minor sale. It does not provide information to assess the company's performance or future prospects.

Positives

• The distributions of shares without payment of consideration (Code J) represent internal re-allocations within FMR LLC's affiliated entities, which can optimize portfolio structure.
• A small portion of shares (268) was sold at $36 per share, indicating a realized value for that specific transaction.

Negatives

• A disposition of 268 shares by Impresa Fund IV LLC, while minor, represents a reduction in direct beneficial ownership by an FMR LLC-affiliated entity.

Risks

• The sale of shares by an insider, even a small amount, could be perceived by some investors as a lack of confidence, though the context of internal distributions suggests a different motivation.

Future Outlook

No forward-looking statements or guidance were provided in this filing, as it primarily reports past insider transactions.

Industry Context

This filing reports an insider transaction and does not provide information directly related to broader industry trends or competitive landscape for Metsera, Inc. It reflects portfolio management decisions by a significant institutional investor.

Corporate Governance

Related Party Transactions

• Multiple transactions coded 'J' represent distributions without payment of consideration between entities affiliated with FMR LLC (e.g., F-Prime Capital Partners Life Sciences Fund VIII LP, Impresa Fund IV LLC, F-Prime Inc.), which are under common control by the Johnson family.

Stakeholder Impact

• Shareholders of Metsera, Inc. may note the minor sale of 268 shares by an FMR LLC-affiliated entity, though the overall impact on the company's stock price is likely negligible given the small volume and context of internal distributions.

Key Dates

Keywords

Metsera, MTSR, FMR LLC, Insider Transaction, Form 4, Beneficial Ownership, Common Stock, Share Distribution, Equity Sale